Clinical Trial

The Effect of Education Given According to Roy's Adaptation Model

Completed
View on ClinicalTrials.gov →
Summary
Background and Aim: Immunosuppressive therapies administered after chronic kidney disease and kidney transplantation are critically important for patients' life adaptation and the continued success of transplantation. However, the process of compliance with immunosuppressive therapy is not limited to regular medication use; it is closely related to multidimensional factors such as disease adjustment, physical adjustment, psychological balance, social functioning, and the individual's level of self-efficacy. This study aimed to examine the effect of Roy's Adaptation Model-based education on the adherence of patients with chronic kidney disease or kidney transplantation undergoing immunosuppressive therapy to immunosuppressive therapy, their adaptation to the disease, and their self-efficacy levels. Material and Methods: This quasi-experimental study with a pretest-posttest control group design was conducted with 78 chronic kidney disease patients who were scheduled to receive immunosuppressive therapy for the first time between November 2024 and June 2025 at the nephrology and transplantation services of a university hospital. Data were collected using the "Patient Information Form," "Immunosuppressive Drug Adherence Scale," "Chronic Disease Coping Scale," and "General Self-Efficacy Scale."
Trial Details
NCT Number NCT07430449
Lead Sponsor Trakya University
Conditions Chronic Kidney Disease, Immunosuppressive Therapy
Enrollment 78 participants
Start Date 2024-11-01
Primary Completion 2025-06-15 (estimated)
Study Completion 2025-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-24